Actualité
[PUBLICATION] The Effect of SMN Gene Dosage on ALS Risk and Disease Severity
- Recherche,
- Santé-Sciences-Technologie,
Date(s)
le 30 avril 2021
Published in Ann Neurol
Collaborative research project led by Prof. Philip Van Damme (Departments of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium) in which Prof. Vourc'h and Corcia participated
/ 1
Contact :
Prof. Patrick Vourc'h : patrick.vourch@univ-tours.fr
